Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
8.15
-0.05 (-0.61%)
At close: Apr 28, 2026, 4:00 PM EDT
8.15
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Kamada Revenue
In the year 2025, Kamada had annual revenue of $180.46M with 12.12% growth. Kamada had revenue of $44.68M in the quarter ending December 31, 2025, with 14.54% growth.
Revenue (ttm)
$180.46M
Revenue Growth
+12.12%
P/S Ratio
2.63
Revenue / Employee
$390,606
Employees
462
Market Cap
474.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.46M | 19.51M | 12.12% |
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 742.90M |
| Organogenesis Holdings | 564.17M |
| Esperion Therapeutics | 403.14M |
| Evolus | 297.18M |
| Ironwood Pharmaceuticals | 296.15M |
| Akebia Therapeutics | 236.20M |
| Canopy Growth | 203.04M |
| SIGA Technologies | 94.57M |
KMDA News
- 18 days ago - Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options - Benzinga
- 18 days ago - Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options - Benzinga
- 18 days ago - David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options - Benzinga
- 18 days ago - Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition - Benzinga
- 18 days ago - Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired - Benzinga
- 18 days ago - Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired - Benzinga
- 18 days ago - Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K - Benzinga
- 18 days ago - Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition - Benzinga